Iloprost approved for treatment of Frostbite by USFDA

The Food and Drug Administration (FDA) has approved Aurlumyn (iloprost) for treatment of severe frostbite in adults which may eventually help reduce the risk of finger or toe amputation.

“This approval provides patients with the first-ever treatment option for severe frostbite,” said Norman Stockbridge, M.D., Ph.D., director of the Division of Cardiology and Nephrology in the FDA’s Center for Drug Evaluation and Research. “Having this new option provides physicians with a tool that will help prevent the lifechanging amputation of one’s frostbitten fingers or toes.”

For the full story, check out the link given below:

FDA Approves Iloprost For Treatment Of Frostbite